Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan · Delayed Price · Currency is JPY 2,297.00
+116.50 (5.34%)
At close: Jan 30, 2026
Sumitomo Pharma Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 110,092 | 23,635 | -314,929 | -96,714 | 40,600 | 36,829 |
Depreciation & Amortization | 21,606 | 25,562 | 37,765 | 41,263 | 38,348 | 22,673 |
Loss (Gain) From Sale of Assets | -62,580 | 5,189 | 180,857 | 75,850 | 769 | 18,989 |
Loss (Gain) From Sale of Investments | - | - | -5,890 | -24,735 | - | - |
Other Operating Activities | 600 | 14,087 | -37,226 | -25,236 | -41,871 | -34,818 |
Change in Accounts Receivable | -27,133 | -909 | 23,390 | 51,218 | -6,097 | 185 |
Change in Inventory | 18,545 | 18,837 | -11,795 | 4,560 | 5,356 | -10,039 |
Change in Accounts Payable | -4,728 | -25,868 | 5,645 | 5,318 | -28,669 | -320 |
Change in Other Net Operating Assets | 2,826 | -44,033 | -119,710 | -19,587 | 22,803 | 102,102 |
Operating Cash Flow | 53,277 | 16,500 | -241,893 | 11,937 | 31,239 | 135,601 |
Operating Cash Flow Growth | - | - | - | -61.79% | -76.96% | 193.97% |
Capital Expenditures | -6,185 | -8,498 | -10,771 | -8,467 | -7,347 | -6,048 |
Sale of Property, Plant & Equipment | 1,202 | 2,208 | 434 | 1,322 | 1,313 | 21,520 |
Cash Acquisitions | -3,469 | - | - | - | - | - |
Divestitures | 31,935 | 1,458 | 8,605 | 30,172 | - | - |
Sale (Purchase) of Intangibles | -1,079 | -3,804 | -4,959 | 7,840 | -6,147 | -4,758 |
Investment in Securities | 2,164 | 106,846 | 29,727 | 3,821 | -6,433 | -1,225 |
Other Investing Activities | 2,116 | 1,544 | - | 2,047 | -797 | 225 |
Investing Cash Flow | 26,684 | 99,754 | 33,036 | 52,419 | -18,278 | 8,875 |
Short-Term Debt Issued | - | - | 84,000 | 85,559 | 29 | - |
Long-Term Debt Issued | - | 139,487 | - | - | - | 243,927 |
Total Debt Issued | 146,187 | 139,487 | 84,000 | 85,559 | 29 | 243,927 |
Short-Term Debt Repaid | - | -181,972 | - | - | - | -265,000 |
Long-Term Debt Repaid | - | -70,000 | - | -20,060 | -4,960 | -2,960 |
Total Debt Repaid | -258,272 | -251,972 | - | -20,060 | -4,960 | -267,960 |
Net Debt Issued (Repaid) | -112,085 | -112,485 | 84,000 | 65,499 | -4,931 | -24,033 |
Common Dividends Paid | -3 | -3 | -2,792 | -11,125 | -11,126 | -11,120 |
Other Financing Activities | -113 | 3,652 | -3,357 | -201,191 | -5,369 | -22,062 |
Financing Cash Flow | -112,201 | -108,836 | 77,851 | -146,817 | -21,426 | -57,215 |
Foreign Exchange Rate Adjustments | 4,170 | -177 | 15,440 | 24,090 | 17,751 | 4,729 |
Miscellaneous Cash Flow Adjustments | -13,172 | -13,172 | 1,135 | -1,135 | - | - |
Net Cash Flow | -41,242 | -5,931 | -114,431 | -59,506 | 9,286 | 91,990 |
Free Cash Flow | 47,092 | 8,002 | -252,664 | 3,470 | 23,892 | 129,553 |
Free Cash Flow Growth | - | - | - | -85.48% | -81.56% | 237.33% |
Free Cash Flow Margin | 10.39% | 2.01% | -80.32% | 0.63% | 4.27% | 25.11% |
Free Cash Flow Per Share | 118.53 | 20.14 | -635.97 | 8.73 | 60.14 | 326.09 |
Cash Interest Paid | 3,658 | 4,361 | 3,734 | 2,424 | 2,500 | 2,229 |
Cash Income Tax Paid | 4,454 | -12,182 | 37,595 | 25,450 | 42,331 | 35,035 |
Levered Free Cash Flow | 40,299 | -10,850 | -253,962 | 45,988 | 15,575 | 85,101 |
Unlevered Free Cash Flow | 59,192 | -6,962 | -251,529 | 47,638 | 17,431 | 86,624 |
Change in Working Capital | -23,556 | -51,973 | -102,470 | 41,509 | -6,607 | 91,928 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.